Effects of mepartricin on estradiol and testosterone serum levels and on prostatic estrogen, androgen and adrenergic receptor concentrations in adult rats

Pharmacological Research

Volumn 44, Issue 2, 2001, Pages 141-147

  Re, G ^a   Badino, P ^a   Odore, R ^a   Vigo, D ^b   Bonabello, A ^c   Rabino, S ^a   Capello, F ^a   Bruzzese, T ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Societa Prodotti Antibiotici S p A   (Italy)

Author keywords

Mepartricin; Prostate; Rat; Receptors; Steroids

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; ANDROGEN RECEPTOR; ANTIESTROGEN; BETA ADRENERGIC RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; MEPARTRICIN; STEROID RECEPTOR; TESTOSTERONE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; ESTRADIOL BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RAT; TESTOSTERONE BLOOD LEVEL;

EID: 0034917555     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2001.0846     Document Type: Article

References (44)

1. The pathogenesis of benign prostatic hyperplasia
2. Benign prostatic hyperplasia
3. The development of human benign prostatic hyperplasia with age
4. Common characteristics of human and canine benign prostatic hyperplasia
5. Agerelated changes in the prostate and testes of the Beagle dog
6. Regulation of the prostatic growth
7. Androgens
8. Prostatic Diseases
9. Endocrine and cellular factors in the development of human benign prostatic hypertrophy
10. Steroid hormones and the pathogenesis of benign prostatic hyperplasia
11. Changes in the endocrine environment of the human prostate transition zone with aging: Simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition
12. Metabolism of androgens and estrogens in the human benign prostatic hyperplasia (BPH)
13. Nuclei of stroma: Site of highest estrogen concentration in human benign prostatic hyperplasia
14. Urinary hormone excretion in benign prostatic hyperplasia
15. Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17β-estradiol
16. Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic prostate: Oestrogen regulation of the androgen receptors
17. Endocrine therapies for symptomatic benign prostatic hyperplasia
18. Estrogen suppression as a pharmacotherapeutic strategy in the medical treatment of benign prostatic hyperplasia: Evidence for its efficacy from studies with mepartricin
19. Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists
20. Alpha adrenergic blockers in the treatment of benign hyperplasia of the prostate
21. Modulating effect of estrogen and testosterone on prostatic stromal cell phenotype differentiation induced by noradrenaline and doxazosin
22. Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue
23. Effetto del trattamento con mepartricina sulle concentrazioni dei recettori per il fattore di crescita insulin-like growth factor-I (IGF-I) nel tessuto adenomatoso umano
24. Effetto del trattamento con mepartricina sulla concentrazione dei recettori per il fattore di crescita insulin-like growth factor-I (IGF-I) nel tessuto adenomatoso umano
25. Pharmacokinetics of mepartricin. Note 1: Absorption excretion of its insoluble form
26. Faecal elimination of steroids in rats after oral administration of mepartricin
27. Effects of mepartricin, a polyene macrolide agent, on fecal excretion and serum concentration of estrogen and number of prostatic estrogen receptors in immature rats
28. Regulation of uterine estrogen receptors by beta-adrenergic stimulation in immature rats
29. Identification of β-adrenoceptor subtypes in bovine ovarian and myometrial cell membranes
30. Protein measurement with the Folin phenol reagent
31. Androgen receptor assay
32. The attraction of proteins for small molecules and ions
33. 1- and β-adrenoceptor concentrations in normal and affected Great Danes
34. Effects of mepartricin (S-160) on spontaneous canine benign prostatic hyperplasia
35. Effect of aging on endogenous level of 5α-dihydrotestosterone, testosterone, estradiol and estrone in epithelium and stroma of normal and hyperplastic human prostate
36. Mechanisms of steroid hormone action
37. Effects of orchiectomy on the alpha adrenergic contractile response of dog prostate
38. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia
39. Tamsulosin and chlormadinone for the treatment of benign prostatic hyperplasia
40. 1-adrenoceptor expression in rat prostate
41. Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate
42. Beta-adrenoceptor-mediated inhibition of alpha1-adrenoceptor-mediated and field stimulation induced contractile responses in the prostate of the guinea pig
43. A possible role of decrease relaxation mediated by beta-adrenoceptors in bladder outlet obstruction by benign prostatic hyperplasia